Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 415

1.

Oncologist uptake of comprehensive genomic profile guided targeted therapy.

Nesline MK, DePietro P, Dy GK, Early A, Papanicolau-Sengos A, Conroy JM, Lenzo FL, Glenn ST, Chen H, Grand'Maison A, Boland P, Ernstoff MS, Puzanov I, Edge S, Akers S, Opyrchal M, Chatta G, Odunsi K, Frederick P, Lele S, Gardner M, Morrison C.

Oncotarget. 2019 Jul 23;10(45):4616-4629. doi: 10.18632/oncotarget.27047. eCollection 2019 Jul 23.

2.

Accuracy of Postoperative Risk Scores for Survival Prediction in Interagency Registry for Mechanically Assisted Circulatory Support Profile 1 Continuous-Flow Left Ventricular Assist Device Recipients.

Critsinelis AC, Lamba H, Nguyen MT, Conroy JR, Cheema FH, Civitello AB, Delgado RM, Nair AP, Oberton SB, Rosengart TK, Frazier OH, Morgan JA, Chatterjee S.

ASAIO J. 2019 Jul 12. doi: 10.1097/MAT.0000000000001044. [Epub ahead of print]

PMID:
31335367
3.

Evaluating the ability of citizen scientists to identify bumblebee (Bombus) species.

Falk S, Foster G, Comont R, Conroy J, Bostock H, Salisbury A, Kilbey D, Bennett J, Smith B.

PLoS One. 2019 Jun 24;14(6):e0218614. doi: 10.1371/journal.pone.0218614. eCollection 2019.

4.

Cellular Metabolomics by a Universal Redox-Reactive Nanosensors Array: From the Cell Level to Tumor-on-a-Chip Analysis.

Krivitsky V, Zverzhinetsky M, Krivitsky A, Hsiung LC, Naddaka V, Gabriel I, Lefler S, Conroy J, Burstein L, Patolsky F.

Nano Lett. 2019 Apr 10;19(4):2478-2488. doi: 10.1021/acs.nanolett.9b00052. Epub 2019 Mar 22.

PMID:
30884235
5.

On a two-truths phenomenon in spectral graph clustering.

Priebe CE, Park Y, Vogelstein JT, Conroy JM, Lyzinski V, Tang M, Athreya A, Cape J, Bridgeford E.

Proc Natl Acad Sci U S A. 2019 Mar 26;116(13):5995-6000. doi: 10.1073/pnas.1814462116. Epub 2019 Mar 8.

6.

Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients.

Pabla S, Conroy JM, Nesline MK, Glenn ST, Papanicolau-Sengos A, Burgher B, Hagen J, Giamo V, Andreas J, Lenzo FL, Yirong W, Dy GK, Yau E, Early A, Chen H, Bshara W, Madden KG, Shirai K, Dragnev K, Tafe LJ, Marin D, Zhu J, Clarke J, Labriola M, McCall S, Zhang T, Zibelman M, Ghatalia P, Araujo-Fernandez I, Singavi A, George B, MacKinnon AC, Thompson J, Singh R, Jacob R, Dressler L, Steciuk M, Binns O, Kasuganti D, Shah N, Ernstoff M, Odunsi K, Kurzrock R, Gardner M, Galluzzi L, Morrison C.

J Immunother Cancer. 2019 Feb 1;7(1):27. doi: 10.1186/s40425-019-0506-3.

7.

Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors.

Conroy JM, Pabla S, Nesline MK, Glenn ST, Papanicolau-Sengos A, Burgher B, Andreas J, Giamo V, Wang Y, Lenzo FL, Bshara W, Khalil M, Dy GK, Madden KG, Shirai K, Dragnev K, Tafe LJ, Zhu J, Labriola M, Marin D, McCall SJ, Clarke J, George DJ, Zhang T, Zibelman M, Ghatalia P, Araujo-Fernandez I, de la Cruz-Merino L, Singavi A, George B, MacKinnon AC, Thompson J, Singh R, Jacob R, Kasuganti D, Shah N, Day R, Galluzzi L, Gardner M, Morrison C.

J Immunother Cancer. 2019 Jan 24;7(1):18. doi: 10.1186/s40425-018-0489-5.

8.

Comparison of SureSelect and Nextera Exome Capture Performance in Single-Cell Sequencing.

Huss WJ, Hu Q, Glenn ST, Gangavarapu KJ, Wang J, Luce JD, Quinn PK, Brese EA, Zhan F, Conroy JM, Paragh G, Foster BA, Morrison CD, Liu S, Wei L.

Hum Hered. 2018;83(3):153-162. doi: 10.1159/000490506. Epub 2019 Jan 22.

9.

Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing.

Dy GK, Nesline MK, Papanicolau-Sengos A, DePietro P, LeVea CM, Early A, Chen H, Grand'Maison A, Boland P, Ernstoff MS, Edge S, Akers S, Opyrchal M, Chatta G, Odunsi K, Pabla S, Conroy JM, Glenn ST, DeFedericis HT, Burgher B, Andreas J, Giamo V, Qin M, Wang Y, Kanehira K, Lenzo FL, Frederick P, Lele S, Galluzzi L, Kuvshinoff B, Morrison C.

BMC Med Inform Decis Mak. 2019 Jan 18;19(1):14. doi: 10.1186/s12911-019-0743-x.

10.

Analysis of mutations in primary and metastatic synovial sarcoma.

Xing Z, Wei L, Jiang X, Conroy J, Glenn S, Bshara W, Yu T, Pao A, Tanaka S, Kawai A, Choi C, Wang J, Liu S, Morrison C, Yu YE.

Oncotarget. 2018 Dec 7;9(96):36878-36888. doi: 10.18632/oncotarget.26416. eCollection 2018 Dec 7.

11.

Identification of targets for prostate cancer immunotherapy.

Papanicolau-Sengos A, Yang Y, Pabla S, Lenzo FL, Kato S, Kurzrock R, DePietro P, Nesline M, Conroy J, Glenn S, Chatta G, Morrison C.

Prostate. 2019 Apr;79(5):498-505. doi: 10.1002/pros.23756. Epub 2019 Jan 6.

PMID:
30614027
12.

PD-L2 amplification and durable disease stabilization in patient with urothelial carcinoma receiving pembrolizumab.

George S, Papanicolau-Sengos A, Lenzo FL, Conroy JM, Nesline M, Pabla S, Glenn ST, Burgher B, Andreas J, Giamo V, Qin M, Wang Y, Galluzzi L, Morrison C.

Oncoimmunology. 2018 May 29;7(12):e1460298. doi: 10.1080/2162402X.2018.1460298. eCollection 2018.

13.

Complement C3a receptor modulates embryonic neural progenitor cell proliferation and cognitive performance.

Coulthard LG, Hawksworth OA, Conroy J, Lee JD, Woodruff TM.

Mol Immunol. 2018 Sep;101:176-181. doi: 10.1016/j.molimm.2018.06.271. Epub 2018 Jun 27.

PMID:
30449309
14.

Hardware Implementation of an Adaptive Data Acquisition System for Real-World EEG.

Poirier CJ, Gadfort P, Dixon AMR, Nonte MW, Conroy JK, Hairston WD.

Conf Proc IEEE Eng Med Biol Soc. 2018 Jul;2018:3294-3297. doi: 10.1109/EMBC.2018.8513037.

PMID:
30441094
15.

BRET-based assay to monitor EGFR transactivation by the AT1R reveals Gq/11 protein-independent activation and AT1R-EGFR complexes.

O'Brien SL, Johnstone EKM, Devost D, Conroy J, Reichelt ME, Purdue BW, Ayoub MA, Kawai T, Inoue A, Eguchi S, Hébert TE, Pfleger KDG, Thomas WG.

Biochem Pharmacol. 2018 Dec;158:232-242. doi: 10.1016/j.bcp.2018.10.017. Epub 2018 Oct 19.

PMID:
30347205
16.

Medial orbitofrontal inactivation does not affect economic choice.

Gardner MP, Conroy JC, Styer CV, Huynh T, Whitaker LR, Schoenbaum G.

Elife. 2018 Oct 3;7. pii: e38963. doi: 10.7554/eLife.38963.

17.

Mechanical prosthetic valve malfunction diagnosed by gated non-contrast computed tomography.

Kassam Z, Brinster D, Poon M, Conroy JM, Kronzon I.

Eur Heart J Cardiovasc Imaging. 2018 Dec 1;19(12):1428. doi: 10.1093/ehjci/jey124. No abstract available. Erratum in: Eur Heart J Cardiovasc Imaging. 2018 Dec 1;19(12):1427.

PMID:
30203069
18.

Brief, But Not Prolonged, Pauses in the Firing of Midbrain Dopamine Neurons Are Sufficient to Produce a Conditioned Inhibitor.

Chang CY, Gardner MPH, Conroy JC, Whitaker LR, Schoenbaum G.

J Neurosci. 2018 Oct 10;38(41):8822-8830. doi: 10.1523/JNEUROSCI.0144-18.2018. Epub 2018 Sep 4.

19.

OncoKids: A Comprehensive Next-Generation Sequencing Panel for Pediatric Malignancies.

Hiemenz MC, Ostrow DG, Busse TM, Buckley J, Maglinte DT, Bootwalla M, Done J, Ji J, Raca G, Ryutov A, Xu X, Zhen CJ, Conroy JM, Hazard FK, Deignan JL, Rogers BB, Treece AL, Parham DM, Gai X, Judkins AR, Triche TJ, Biegel JA.

J Mol Diagn. 2018 Nov;20(6):765-776. doi: 10.1016/j.jmoldx.2018.06.009. Epub 2018 Aug 20.

PMID:
30138724
20.

Identification of Positive Allosteric Modulators of the D1 Dopamine Receptor That Act at Diverse Binding Sites.

Luderman KD, Conroy JL, Free RB, Southall N, Ferrer M, Sanchez-Soto M, Moritz AE, Willette BKA, Fyfe TJ, Jain P, Titus S, Hazelwood LA, Aubé J, Lane JR, Frankowski KJ, Sibley DR.

Mol Pharmacol. 2018 Oct;94(4):1197-1209. doi: 10.1124/mol.118.113175. Epub 2018 Aug 1.

21.

Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden.

Morrison C, Pabla S, Conroy JM, Nesline MK, Glenn ST, Dressman D, Papanicolau-Sengos A, Burgher B, Andreas J, Giamo V, Qin M, Wang Y, Lenzo FL, Omilian A, Bshara W, Zibelman M, Ghatalia P, Dragnev K, Shirai K, Madden KG, Tafe LJ, Shah N, Kasuganti D, de la Cruz-Merino L, Araujo I, Saenger Y, Bogardus M, Villalona-Calero M, Diaz Z, Day R, Eisenberg M, Anderson SM, Puzanov I, Galluzzi L, Gardner M, Ernstoff MS.

J Immunother Cancer. 2018 May 9;6(1):32. doi: 10.1186/s40425-018-0344-8.

22.

What's Your Style? Enhanced Interprofessional Communication and Practice Using the Communication Wheel.

Schwartz L, El-Banna M, Conroy JF, Browne J.

Nurse Educ. 2019 Jan/Feb;44(1):20-24. doi: 10.1097/NNE.0000000000000509.

PMID:
29406400
23.

Lateral Orbitofrontal Inactivation Dissociates Devaluation-Sensitive Behavior and Economic Choice.

Gardner MPH, Conroy JS, Shaham MH, Styer CV, Schoenbaum G.

Neuron. 2017 Dec 6;96(5):1192-1203.e4. doi: 10.1016/j.neuron.2017.10.026. Epub 2017 Nov 16.

24.

Analytical Validation of a Next-Generation Sequencing Assay to Monitor Immune Responses in Solid Tumors.

Conroy JM, Pabla S, Glenn ST, Burgher B, Nesline M, Papanicolau-Sengos A, Andreas J, Giamo V, Lenzo FL, Hyland FCL, Omilian A, Bshara W, Qin M, He J, Puzanov I, Ernstoff MS, Gardner M, Galluzzi L, Morrison C.

J Mol Diagn. 2018 Jan;20(1):95-109. doi: 10.1016/j.jmoldx.2017.10.001. Epub 2017 Oct 20.

PMID:
29061374
25.

LAGOS-NE: a multi-scaled geospatial and temporal database of lake ecological context and water quality for thousands of US lakes.

Soranno PA, Bacon LC, Beauchene M, Bednar KE, Bissell EG, Boudreau CK, Boyer MG, Bremigan MT, Carpenter SR, Carr JW, Cheruvelil KS, Christel ST, Claucherty M, Collins SM, Conroy JD, Downing JA, Dukett J, Fergus CE, Filstrup CT, Funk C, Gonzalez MJ, Green LT, Gries C, Halfman JD, Hamilton SK, Hanson PC, Henry EN, Herron EM, Hockings C, Jackson JR, Jacobson-Hedin K, Janus LL, Jones WW, Jones JR, Keson CM, King KBS, Kishbaugh SA, Lapierre JF, Lathrop B, Latimore JA, Lee Y, Lottig NR, Lynch JA, Matthews LJ, McDowell WH, Moore KEB, Neff BP, Nelson SJ, Oliver SK, Pace ML, Pierson DC, Poisson AC, Pollard AI, Post DM, Reyes PO, Rosenberry DO, Roy KM, Rudstam LG, Sarnelle O, Schuldt NJ, Scott CE, Skaff NK, Smith NJ, Spinelli NR, Stachelek JJ, Stanley EH, Stoddard JL, Stopyak SB, Stow CA, Tallant JM, Tan PN, Thorpe AP, Vanni MJ, Wagner T, Watkins G, Weathers KC, Webster KE, White JD, Wilmes MK, Yuan S.

Gigascience. 2017 Dec 1;6(12):1-22. doi: 10.1093/gigascience/gix101.

26.

Clinical spectrum and genotype-phenotype associations of KCNA2-related encephalopathies.

Masnada S, Hedrich UBS, Gardella E, Schubert J, Kaiwar C, Klee EW, Lanpher BC, Gavrilova RH, Synofzik M, Bast T, Gorman K, King MD, Allen NM, Conroy J, Ben Zeev B, Tzadok M, Korff C, Dubois F, Ramsey K, Narayanan V, Serratosa JM, Giraldez BG, Helbig I, Marsh E, O'Brien M, Bergqvist CA, Binelli A, Porter B, Zaeyen E, Horovitz DD, Wolff M, Marjanovic D, Caglayan HS, Arslan M, Pena SDJ, Sisodiya SM, Balestrini S, Syrbe S, Veggiotti P, Lemke JR, Møller RS, Lerche H, Rubboli G.

Brain. 2017 Sep 1;140(9):2337-2354. doi: 10.1093/brain/awx184.

PMID:
29050392
27.

Comparative reliability and diagnostic performance of conventional 3T magnetic resonance imaging and 1.5T magnetic resonance arthrography for the evaluation of internal derangement of the hip.

Chopra A, Grainger AJ, Dube B, Evans R, Hodgson R, Conroy J, Macdonald D, Robinson P.

Eur Radiol. 2018 Mar;28(3):963-971. doi: 10.1007/s00330-017-5069-4. Epub 2017 Oct 6.

28.

Cost of exome sequencing in epileptic encephalopathy: is it 'worth it'?

Forman EB, Gorman KM, Conroy J, Arthur N, Grant C, Ennis S, Allen NM, Lynch SA, King MD.

Arch Dis Child. 2018 Mar;103(3):304. doi: 10.1136/archdischild-2017-313240. Epub 2017 Sep 22. No abstract available.

PMID:
28939639
29.

Novel SMC1A variant and epilepsy of infancy with migrating focal seizures: Expansion of the phenotype.

Gorman KM, Forman E, Conroy J, Allen NM, Shahwan A, Lynch SA, Ennis S, King MD.

Epilepsia. 2017 Jul;58(7):1301-1302. doi: 10.1111/epi.13794. No abstract available.

30.
31.

A global database of nitrogen and phosphorus excretion rates of aquatic animals.

Vanni MJ, McIntyre PB, Allen D, Arnott DL, Benstead JP, Berg DJ, Brabrand Å, Brosse S, Bukaveckas PA, Caliman A, Capps KA, Carneiro LS, Chadwick NE, Christian AD, Clarke A, Conroy JD, Cross WF, Culver DA, Dalton CM, Devine JA, Domine LM, Evans-White MA, Faafeng BA, Flecker AS, Gido KB, Godinot C, Guariento RD, Haertel-Borer S, Hall RO, Henry R, Herwig BR, Hicks BJ, Higgins KA, Hood JM, Hopton ME, Ikeda T, James WF, Jansen HM, Johnson CR, Koch BJ, Lamberti GA, Lessard-Pilon S, Maerz JC, Mather ME, McManamay RA, Milanovich JR, Morgan DKJ, Moslemi JM, Naddafi R, Nilssen JP, Pagano M, Pilati A, Post DM, Roopin M, Rugenski AT, Schaus MH, Shostell J, Small GE, Solomon CT, Sterrett SC, Strand Ø, Tarvainen M, Taylor JM, Torres-Gerald LE, Turner CB, Urabe J, Uye SI, Ventelä AM, Villeger S, Whiles MR, Wilhelm FM, Wilson HF, Xenopoulos MA, Zimmer KD.

Ecology. 2017 May;98(5):1475. doi: 10.1002/ecy.1792. Epub 2017 Apr 18.

32.

Symmetrical thalamic calcification: A trio whole exome sequencing negative series.

Gorman KM, Aird JJ, Conroy J, Devaney D, Farrell M, King MD.

Brain Dev. 2017 May;39(5):426-430. doi: 10.1016/j.braindev.2016.12.001. Epub 2017 Jan 4.

PMID:
28063749
33.

Robust detection of immune transcripts in FFPE samples using targeted RNA sequencing.

Paluch BE, Glenn ST, Conroy JM, Papanicolau-Sengos A, Bshara W, Omilian AR, Brese E, Nesline M, Burgher B, Andreas J, Odunsi K, Eng K, He J, Qin M, Gardner M, Galluzzi L, Morrison CD.

Oncotarget. 2017 Jan 10;8(2):3197-3205. doi: 10.18632/oncotarget.13691.

34.

Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenografts.

Wei L, Chintala S, Ciamporcero E, Ramakrishnan S, Elbanna M, Wang J, Hu Q, Glenn ST, Murakami M, Liu L, Gomez EC, Sun Y, Conroy J, Miles KM, Malathi K, Ramaiah S, Anbarasu A, Woloszynska-Read A, Johnson CS, Conroy J, Liu S, Morrison CD, Pili R.

Oncotarget. 2016 Nov 22;7(47):76374-76389. doi: 10.18632/oncotarget.13062.

35.

Pitfalls of improperly procured adjacent non-neoplastic tissue for somatic mutation analysis using next-generation sequencing.

Wei L, Papanicolau-Sengos A, Liu S, Wang J, Conroy JM, Glenn ST, Brese E, Hu Q, Miles KM, Burgher B, Qin M, Head K, Omilian AR, Bshara W, Krolewski J, Trump DL, Johnson CS, Morrison CD.

BMC Med Genomics. 2016 Oct 19;9(1):64.

36.

Atypical benign partial epilepsy of childhood with acquired neurocognitive, lexical semantic, and autistic spectrum disorder.

Allen NM, Conroy J, Deonna T, McCreary D, McGettigan P, Madigan C, Carter I, Ennis S, Lynch SA, Shahwan A, King MD.

Epilepsy Behav Case Rep. 2016 Apr 23;6:42-8. doi: 10.1016/j.ebcr.2016.04.003. eCollection 2016.

37.

Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators.

Wei L, Wang J, Lampert E, Schlanger S, DePriest AD, Hu Q, Gomez EC, Murakam M, Glenn ST, Conroy J, Morrison C, Azabdaftari G, Mohler JL, Liu S, Heemers HV.

Eur Urol. 2017 Feb;71(2):183-192. doi: 10.1016/j.eururo.2016.07.008. Epub 2016 Jul 21.

38.

Novel European SLC1A4 variant: infantile spasms and population ancestry analysis.

Conroy J, Allen NM, Gorman K, O'Halloran E, Shahwan A, Lynch B, Lynch SA, Ennis S, King MD.

J Hum Genet. 2016 Aug;61(8):761-4. doi: 10.1038/jhg.2016.44. Epub 2016 May 19.

PMID:
27193218
39.

Whole-genome sequencing of a malignant granular cell tumor with metabolic response to pazopanib.

Wei L, Liu S, Conroy J, Wang J, Papanicolau-Sengos A, Glenn ST, Murakami M, Liu L, Hu Q, Conroy J, Miles KM, Nowak DE, Liu B, Qin M, Bshara W, Omilian AR, Head K, Bianchi M, Burgher B, Darlak C, Kane J, Merzianu M, Cheney R, Fabiano A, Salerno K, Talati C, Khushalani NI, Trump DL, Johnson CS, Morrison CD.

Cold Spring Harb Mol Case Stud. 2015 Oct;1(1):a000380. doi: 10.1101/mcs.a000380.

40.

Collecting duct carcinoma of the kidney is associated with CDKN2A deletion and SLC family gene up-regulation.

Wang J, Papanicolau-Sengos A, Chintala S, Wei L, Liu B, Hu Q, Miles KM, Conroy JM, Glenn ST, Costantini M, Magi-Galluzzi C, Signoretti S, Choueiri T, Gallucci M, Sentinelli S, Fazio VM, Poeta ML, Liu S, Morrison C, Pili R.

Oncotarget. 2016 May 24;7(21):29901-15. doi: 10.18632/oncotarget.9093.

41.

Unexplained early onset epileptic encephalopathy: Exome screening and phenotype expansion.

Allen NM, Conroy J, Shahwan A, Lynch B, Correa RG, Pena SD, McCreary D, Magalhães TR, Ennis S, Lynch SA, King MD.

Epilepsia. 2016 Jan;57(1):e12-7. doi: 10.1111/epi.13250. Epub 2015 Dec 9.

42.

Reactions to cadmium stress in a cadmium-tolerant variety of cabbage (Brassica oleracea L.): is cadmium tolerance necessarily desirable in food crops?

Jinadasa N, Collins D, Holford P, Milham PJ, Conroy JP.

Environ Sci Pollut Res Int. 2016 Mar;23(6):5296-306. doi: 10.1007/s11356-015-5779-6. Epub 2015 Nov 13.

PMID:
26564184
43.

NAPB - a novel SNARE-associated protein for early-onset epileptic encephalopathy.

Conroy J, Allen NM, Gorman KM, Shahwan A, Ennis S, Lynch SA, King MD.

Clin Genet. 2016 Feb;89(2):E1-3. doi: 10.1111/cge.12648. Epub 2015 Aug 28.

PMID:
26235277
44.

MAC: identifying and correcting annotation for multi-nucleotide variations.

Wei L, Liu LT, Conroy JR, Hu Q, Conroy JM, Morrison CD, Johnson CS, Wang J, Liu S.

BMC Genomics. 2015 Aug 1;16:569. doi: 10.1186/s12864-015-1779-7.

45.

Determining the Tsallis parameter via maximum entropy.

Conroy JM, Miller HG.

Phys Rev E Stat Nonlin Soft Matter Phys. 2015 May;91(5):052112. Epub 2015 May 11.

PMID:
26066124
46.

The impact of DNA input amount and DNA source on the performance of whole-exome sequencing in cancer epidemiology.

Zhu Q, Hu Q, Shepherd L, Wang J, Wei L, Morrison CD, Conroy JM, Glenn ST, Davis W, Kwan ML, Ergas IJ, Roh JM, Kushi LH, Ambrosone CB, Liu S, Yao S.

Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1207-13. doi: 10.1158/1055-9965.EPI-15-0205. Epub 2015 May 19.

47.

Chromosomal microarray in unexplained severe early onset epilepsy - A single centre cohort.

Allen NM, Conroy J, Shahwan A, Ennis S, Lynch B, Lynch SA, King MD.

Eur J Paediatr Neurol. 2015 Jul;19(4):390-4. doi: 10.1016/j.ejpn.2015.03.010. Epub 2015 Apr 10.

PMID:
25920948
48.

Common polygenic variation in coeliac disease and confirmation of ZNF335 and NIFA as disease susceptibility loci.

Coleman C, Quinn EM, Ryan AW, Conroy J, Trimble V, Mahmud N, Kennedy N, Corvin AP, Morris DW, Donohoe G, O'Morain C, MacMathuna P, Byrnes V, Kiat C, Trynka G, Wijmenga C, Kelleher D, Ennis S, Anney RJ, McManus R.

Eur J Hum Genet. 2016 Feb;24(2):291-7. doi: 10.1038/ejhg.2015.87. Epub 2015 Apr 29.

49.

PNA-Based Multivalent Scaffolds Activate the Dopamine D2 Receptor.

Dix AV, Conroy JL, George Rosenker KM, Sibley DR, Appella DH.

ACS Med Chem Lett. 2015 Mar 13;6(4):425-9. doi: 10.1021/ml500478m. eCollection 2015 Apr 9.

50.

SCNVSim: somatic copy number variation and structure variation simulator.

Qin M, Liu B, Conroy JM, Morrison CD, Hu Q, Cheng Y, Murakami M, Odunsi AO, Johnson CS, Wei L, Liu S, Wang J.

BMC Bioinformatics. 2015 Feb 28;16:66. doi: 10.1186/s12859-015-0502-7.

Supplemental Content

Loading ...
Support Center